Full-Time

Scientist – In Vitro Pharmacology

Updated on 12/21/2024

Neurocrine Biosciences

Neurocrine Biosciences

1,001-5,000 employees

Biotechnology
Healthcare

Compensation Overview

$88k - $127.5kAnnually

+ Bonus + Equity Incentive Program

Junior, Mid, Senior

San Diego, CA, USA

Category
Lab & Research
Life Sciences
Required Skills
Data Analysis
Requirements
  • BS/BA degree in scientific field and 2+ years of in vitro pharmacology experience; Preferred experience includes: SPR and BLI for characterizing protein-protein interactions and binding kinetics, related assay development and troubleshooting OR
  • MS/MA degree in scientific field and some relevant industry experience OR
  • PhD in biology or related field preferred and some experience with antibody drug discovery, antibody characterizations, assay development and optimization and related troubleshooting, experience with SPR and BLI is required. Preferred experience includes: SPR and BLI for characterizing antibody-protein interactions with strong assay development and troubleshooting skills
  • Recognizes fundamental anomalies in data points and identifies issues in experiments / processes
  • Begins to understand how to think outside of the technical process and consider the impact decisions will have on the broader scientific goals
  • Strong knowledge of one scientific discipline
  • Good knowledge of scientific principles, methods and techniques
  • Good knowledge and demonstrated ability working with a variety of laboratory equipment/tools
  • Ability to work as part of a team
  • Strong computer skills
  • Good communications, problem-solving, analytical thinking skills
  • Detail oriented
  • Ability to meet deadlines
  • Good project management skills
  • Demonstrated experience with measuring antibody binding kinetics, pH dependent, competition binding, dual engagement binding studies using Biacore SPR methods
  • Experience with obtaining epitope binning and binding/competition binding studies using Octet BLI methods
  • Ability to QC and troubleshoot experiments.
  • Collaborative and highly motivated
Responsibilities
  • Design, execute, and analyze SPR and BLI experiments to determine antibody affinity (KD), kinetics, pH dependent binding, competition experiments, dual-target engagement, epitope binning against various antigens, including recombinant proteins, Nanodisc, VLP. Experience with cells a plus
  • Independently develop, optimize and troubleshoot protocols to evaluate monospecific and bispecific antibodies, scFv, Fabs, peptides and small molecules
  • Apply extensive QC parameters to data to identify and troubleshoot issues
  • Extensive knowledge of Biacore Insight and Octet Analysis software for data analysis
  • Regular maintenance of SPR and BLI instrumentation
  • Prepare high-quality data reports and presentations for project meetings
  • Collaborate with scientists in a highly matrixed environment across multiple therapeutic areas and function teams
  • Stay current with the latest advancements in SPR, BLI, and antibody, peptide and small molecule characterization techniques
  • Must be highly organized with strong attention to details, and an eye on critical decision-making data generation
Neurocrine Biosciences

Neurocrine Biosciences

View

Company Stage

IPO

Total Funding

N/A

Headquarters

San Diego, California

Founded

1992

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • FDA approval of CRENESSITY opens a new market for CAH treatment.
  • Positive Phase 2 data for NBI-1117568 boosts Neurocrine's mental health portfolio.
  • Recognition as a top workplace enhances Neurocrine's reputation and employee satisfaction.

What critics are saying

  • Increased competition in CAH treatment may impact CRENESSITY's market share.
  • Potential market saturation for INGREZZA due to similar products.
  • CEO transition could lead to strategic misalignment.

What makes Neurocrine Biosciences unique

  • CRENESSITY is the first new CAH treatment in 70 years.
  • INGREZZA SPRINKLE offers a unique formulation for patients with swallowing difficulties.
  • Neurocrine's NBI-1117568 shows promising results for schizophrenia treatment.

Help us improve and share your feedback! Did you find this helpful?